RAVULIZUMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14745CMP | RAVULIZUMAB ravulizumab 1.1 g/11 mL injection, 11 mL vial (PI, CMI) |
1 | 1 | 0 | $24153.99 | $31.60 | $31.60 |
| Available brands | |||||||
| Ultomiris |
RAVULIZUMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14746DMP | RAVULIZUMAB ravulizumab 300 mg/3 mL injection, 3 mL vial (PI, CMI) |
1 | 1 | 0 | $6623.00 | $31.60 | $31.60 |
| Available brands | |||||||
| Ultomiris |
RAVULIZUMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14758RMP | RAVULIZUMAB ravulizumab 1.1 g/11 mL injection, 11 mL vial (PI, CMI) |
1 | 1 | 2 | $24105.11 | $31.60 | $31.60 |
| Available brands | |||||||
| Ultomiris |
RAVULIZUMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14759TMP | RAVULIZUMAB ravulizumab 300 mg/3 mL injection, 3 mL vial (PI, CMI) |
1 | 1 | 0 | $6574.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Ultomiris |
RAVULIZUMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14771KMP | RAVULIZUMAB ravulizumab 300 mg/3 mL injection, 3 mL vial (PI, CMI) |
1 | 1 | 2 | $6623.00 | $31.60 | $31.60 |
| Available brands | |||||||
| Ultomiris |
RAVULIZUMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14776QMP | RAVULIZUMAB ravulizumab 1.1 g/11 mL injection, 11 mL vial (PI, CMI) |
1 | 1 | 2 | $24153.99 | $31.60 | $31.60 |
| Available brands | |||||||
| Ultomiris |
RAVULIZUMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14783CMP | RAVULIZUMAB ravulizumab 1.1 g/11 mL injection, 11 mL vial (PI, CMI) |
1 | 1 | 0 | $24105.11 | $31.60 | $31.60 |
| Available brands | |||||||
| Ultomiris |
RAVULIZUMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14784DMP | RAVULIZUMAB ravulizumab 300 mg/3 mL injection, 3 mL vial (PI, CMI) |
1 | 1 | 2 | $6574.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Ultomiris |
- Legend
- MPMedical Practitioner




